Vivos Therapeutics to Participate at the Benzinga Healthcare Small Cap Conference
Vivos management to present at 2:20 pm Eastern Time on September 29, 2021
Colorado, September 22, 2021
Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (OSA), today announced that Vivos’ Chairman and Chief Executive Officer, Kirk Huntsman, and Vivos’ Chief Financial Officer, Brad Amman, will be presenting at the online Benzinga Healthcare Small Cap Conference at 2:20 pm EST on Wednesday, September 29, 2021. The Benzinga Healthcare Small Cap Conference will be taking place from September 29-30, 2021.
Investors interested in joining the Vivos presentation can register for a free spectator pass at the link below:
A replay of the presentation will be available for view following the presentation on Vivos’ website at: https://vivoslife.com/investor-relations/